Many COVID-19 patients did not show an increase in prothrombin time (PT), assays evaluating the tissue factor pathway and common pathway of coagulation, although slightly prolonged PT was observed in nonsurviving COVID-19 patients. This evidence concerns the gene F2 and COVID-19.